Online citations, reference lists, and bibliographies.
← Back to Search

Role Of Polyanhydrides As Localized Drug Carriers.

J. Jain, Sweta Modi, A. Domb, N. Kumar
Published 2005 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Many drugs that are administered in an unmodified form by conventional systemic routes fail to reach target organs in an effective concentration, or are not effective over a length of time due to a facile metabolism. Various types of targeting delivery systems and devices have been tried over a long period of time to overcome these problems. Targeted delivery or localized drug delivery offers an advantage of reduced body burden and systemic toxicity of the drugs, especially useful for highly toxic drugs like anticancer agents. Local drug delivery via polymer is a simple approach and hypothesized to avoid the above stated problems. Polyanhydrides are a unique class of polymer for drug delivery because some of them demonstrate a near zero order drug release and relatively rapid biodegradation in vivo. Further, the release rate of polyanhydride fabricated device can be altered over a thousand fold by simple changes in the polymer backbone. Hence, these are one of the best-suited polymers for drug delivery, with biodegradability and biocompatibility. The review focuses on the advantages of polyanhydride carriers in localized drug delivery along with their degradability behavior, toxicological profile and role in various disease conditions.
This paper references
10.1163/156856294X00374
Controlled release of macromolecules from a degradable polyanhydride matrix.
W. Dang (1994)
10.1016/S0169-409X(01)00200-9
Biodegradable microspheres for vitreoretinal drug delivery.
R. Herrero-Vanrell (2001)
10.1002/PAT.267
Polyanhydrides with hydrophobic terminals
Michal Y. Krasko (2002)
10.1016/0009-2509(90)80116-V
Development and temporal evolution of erosion fronts in bioerodible controlled release devices
K. Zygourakis (1990)
Pathobiology of restenosis after angioplasty.
C. Haudenschild (1993)
10.1016/S0163-7258(01)00153-X
Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy.
M. R. Bennett (2001)
10.3171/JNS.1989.71.1.0105
Intracerebral drug delivery in rats with lesion-induced memory deficits.
M. Howard (1989)
10.1016/J.IJROBP.2003.09.054
Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy.
Yongbiao Li (2004)
10.1016/0142-9612(95)93260-K
In vivo and in vitro elimination of aliphatic polyanhydrides.
A. Domb (1995)
10.1002/JBM.820200106
Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity.
K. Leong (1986)
10.1016/0735-1097(94)90144-9
Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty.
J. Marmur (1994)
10.1023/A:1018929531410
Controlled Delivery Systems for Proteins Using Polyanhydride Microspheres
Y. Tabata (2004)
10.1016/0305-7372(87)90048-X
Optimizing drug delivery to brain tumors.
N. Greig (1987)
10.1016/S0939-6411(02)00191-1
Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride--P(CBFAS).
Q. Cai (2003)
10.1016/S1461-5347(00)00266-2
Glioblastoma: encouraging the body to fight back.
Senior (2000)
The use of bioerodible polymers and 5-fluorouracil in glaucoma filtration surgery.
D. Lee (1988)
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.
S. B. Green (1983)
10.1016/0735-1097(95)00235-V
Gene therapy for the vulnerable plaque.
L. Feldman (1995)
10.1126/SCIENCE.2119055
Site-specific gene expression in vivo by direct gene transfer into the arterial wall.
E. Nabel (1990)
10.1161/01.CIR.84.1.432
Thrombin and other potential mechanisms underlying restenosis.
J. Wilcox (1991)
10.1161/01.CIR.90.4.2070
Local drug delivery for the prevention of restenosis. Fact, fancy, and future.
A. Lincoff (1994)
10.1007/BF02427833
Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate
R. Tamargo (2006)
10.1016/S0006-8993(98)00860-9
Prolonged seizure suppression by a single implantable polymeric-TRH microdisk preparation
M. Kubek (1998)
10.1002/POLA.1987.080251217
Polyanhydrides. I: Preparation of high molecular weight polyanhydrides
A. Domb (1987)
10.1097/00006123-199804000-00013
Survival and functional status after resection of recurrent glioblastoma multiforme.
F. Barker (1998)
10.3109/03639049009058548
Interstitial Drug Therapy for Brain Tumors: A Case Study
M. Chasin (1990)
10.1038/nrd1414
Targeted therapy for brain tumours
M. Lesniak (2004)
O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
L. Rhines (2000)
10.1023/A:1025695423097
Local Delivery of Minocycline and Systemic BCNU have Synergistic Activity in the Treatment of Intracranial Glioma
J. L. Frazier (2004)
10.1016/S0168-3659(97)00223-X
Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release.
E. Park (1998)
10.1002/JBM.820230209
Brain biocompatibility of a biodegradable, controlled-release polymer in rats.
R. Tamargo (1989)
10.1023/A:1015003232713
Polymer Delivery of Camptothecin against 9L Gliosarcoma: Release, Distribution, and Efficacy
P. Storm (2004)
10.1002/POLA.10973
Aminosalicylate-based biodegradable polymers: Syntheses and in vitro characterization of Poly(anhydride-ester)s and poly(anhydride-amide)s
T. J. Anastasiou (2003)
10.1016/J.EHJ.2004.06.011
Inflammation and restenosis after percutaneous coronary interventions.
K. Toutouzas (2004)
10.1097/00006123-200102000-00032
l-Buthionine Sulfoximine Potentiates the Antitumor Effect of 4-Hydroperoxycyclophosphamide When Administered Locally in a Rat Glioma Model
E. P. Sipos (2001)
In vitro release and antibacterial activity of poly (oleic/linoleic acid dimer: sebacic acid)-gentamicin.
Xiu-fen Yang (2003)
10.1021/CR940351U
Polymeric systems for controlled drug release.
K. Uhrich (1999)
10.1016/0168-3659(95)00009-W
Preparation and evaluation of polyanhydride microspheres containing gonadotropin-releasing hormone (GnRH), for inducing ovulation and spermiation in fish
C. Mylonas (1995)
10.1016/S0169-409X(01)00116-8
Mathematical modeling of bioerodible, polymeric drug delivery systems.
J. Siepmann (2001)
10.1016/S0378-5173(97)00298-6
Effect of geometry on the erosion characteristics of polyanhydride matrices
H. Akbari (1997)
10.1089/JOP.1994.10.471
Pharmacokinetics of etoposide delivery by a bioerodible drug carrier implanted at glaucoma surgery.
P. Uppal (1994)
10.1056/NEJM198012043032303
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.
M. Walker (1980)
Predicting drug release from cylindric polyanhydride matrix discs
A. Göpferich (1995)
10.1161/01.CIR.88.3.1351
Do antisense approaches to the problem of restenosis make sense?
S. Epstein (1993)
10.3171/JNS.1994.80.2.0283
Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.
H. Brem (1994)
10.1055/S-2007-1002586
Local thrombolysis for salvage of occluded bypass grafts.
K. Mathias (1991)
10.1021/MA00009A024
NMR characterization of erodible copolymers
E. Ron (1991)
10.1002/AIC.690411012
Modeling of polymer erosion in three dimensions: Rotationally symmetric devices
A. Göpferich (1995)
10.1097/00000421-198602000-00020
Cancer : Principles and Practice of Oncology
V. Devita (1982)
10.1016/0168-3659(94)90029-9
Controlled release of a local anesthetic from fatty acid dimer based polyanhydride
M. Maniar (1994)
10.1021/BM000081R
Nonlinear fatty acid terminated polyanhydrides.
D. Teomim (2001)
10.1016/0142-9612(96)85757-7
Computer-aided design of bioerodible devices with optimal release characteristics: a cellular automata approach.
K. Zygourakis (1996)
10.1177/000331979504600202
Enhanced Migratory Activity of Vascular Smooth Muscle Cells with High Expression of Platelet-Derived Growth Factor A and B
Ralf Köster (1995)
10.1136/hrt.72.4.309
Gene therapy for cardiovascular disease.
D. Muller (1994)
10.1016/S0169-409X(02)00052-2
Toxicity, biodegradation and elimination of polyanhydrides.
D. Katti (2002)
10.1016/J.POLYMER.2004.04.028
New polyanhydrides derived from C12,C13,C14,C15 dibasic acid: synthesis and characterization
Wen-xun Guo (2004)
Sidebranch patency during main branch stenting: try to keep the branch open immediate and long-term!
A. Colombo (2002)
10.1002/JBM.820241105
Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology.
C. Laurencin (1990)
10.1021/MA00068A006
Modeling of Polymer Erosion
A. Göpferich (1993)
10.1001/ARCHOTOL.1994.01880350050009
Polymer delivery of chemotherapy for squamous cell carcinoma of the head and neck.
A. Shikani (1994)
10.1002/POLA.10651
Poly(ester anhydride)s prepared by the insertion of ricinoleic acid into poly(sebacic acid)
Michal Y. Krasko (2003)
10.1016/S0360-3016(02)03740-9
Tumor treatment by sustained intratumoral release of 5-fluorouracil: effects of drug alone and in combined treatments.
M. Berrada (2002)
10.1016/S0169-409X(02)00054-6
Local drug delivery to the brain.
P. Wang (2002)
10.1056/NEJM198703193161201
Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.
U. Sigwart (1987)
10.1016/S0039-6060(05)80255-7
Prevention of venous thrombosis in microvascular surgery by transmural release of heparin from a polyanhydride polymer.
L. Orloff (1995)
10.1016/S0169-409X(02)00053-4
Polyanhydride implant for antibiotic delivery--from the bench to the clinic.
L. Li (2002)
10.1016/S1535-6108(03)00276-9
Advancing the field of drug delivery: taking aim at cancer.
M. Moses (2003)
10.3171/JNS.1988.68.1.0001
Chemotherapy for malignant gliomas.
P. Kornblith (1988)
10.1023/A:1011995728760
Preparation and Characterization of Carmustine Loaded Polyanhydride Wafers for Treating Brain Tumors
A. Domb (2004)
10.1002/1097-4636(20000905)51:3<352::AID-JBM8>3.0.CO;2-C
Surface and bulk modifications to photocrosslinked polyanhydrides to control degradation behavior.
A. K. Burkoth (2000)
10.1007/s002800050542
Interstitial delivery of carboplatin via biodegradable Polymers is effective against experimental glioma in the rat
A. Olivi (1996)
Polymeric site-specific pharmacotherapy
A. Domb (1994)
10.3171/JNS.1995.82.3.0481
Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
K. Judy (1995)
10.1021/MA00027A003
Synthesis and characterization of biodegradable aromatic anhydride copolymers
J. A. Domb (1992)
10.1016/J.BIOMATERIALS.2004.03.024
Synthesis of novel biodegradable polyanhydrides containing aromatic and glycol functionality for tailoring of hydrophilicity in controlled drug delivery devices.
Brandon M Vogel (2005)
Glaucoma filtration surgery in nonhuman primates using taxol and etoposide in polyanhydride carriers.
H. Jampel (1993)
10.1161/01.RES.76.2.176
c-myc in vasculoproliferative disease.
E. Edelman (1995)
10.1023/A:1016035229961
Morphological Characterization of Polyanhydride Biodegradable Implant Gliadel® During in Vitro and in Vivo Erosion Using Scanning Electron Microscopy
W. Dang (2004)
10.1016/1357-4310(96)88720-X
Transporting therapeutics across the blood-brain barrier.
N. Abbott (1996)
10.1016/0065-2571(93)90006-Y
Role of glutathione in cellular resistance to alkylating agents.
O. Colvin (1993)
10.1016/S0169-409X(96)00483-8
Nanoparticle drug delivery system for restenosis
V. Labhasetwar (1997)
10.1016/0141-3910(87)90074-7
Thermal degradation of poly(O-methacryloyloxybenzoic acid)
J. Román (1987)
Pathologic basis of disease
S. L. Robbins (1974)
10.1161/01.CIR.90.4.1979
Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons.
J. Mitchel (1994)
10.1016/S0168-3659(01)00282-6
Programmable biodegradable implants.
W. Vogelhuber (2001)
10.1023/A:1015801216466
Molecular Weight Changes in Polymer Erosion
A. D’Emanuele (2004)
10.1093/MILMED/151.1.386
Goodman and Gilman's the Pharmacological Basis of Therapeutics
W. Stigelman (1986)
10.3171/JNS.1978.49.3.0333
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.
M. Walker (1978)
10.1172/JCI117036
Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
M. Bennett (1994)
10.1016/S0142-9612(97)00221-4
Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery.
Justin S Hanes (1998)
10.1016/S0378-5173(01)00986-3
Paclitaxel and its formulations.
A. K. Singla (2002)
10.1021/BC034146+
Antigenicity of recombinant proteins after regioselective immobilization onto polyanhydride-based copolymers.
L. Allard (2004)
10.1016/J.POLYMER.2004.03.052
Understanding polyanhydride blend phase behavior using scattering, microscopy, and molecular simulations.
Matt J. Kipper (2004)
10.1021/bk-1976-0033.ch003
Controlled Release from Erodible Slabs, Cylinders, and Spheres
H. Hopfenberg (1976)
10.1002/AIC.690180234
Effect of geometry on the dissolution of pharmaceutical tablets and other solids: Surface detachment kinetics controlling
D. O. Cooney (1972)
10.1002/POLA.1991.080290413
Polyanhydrides. IV. Unsaturated and crosslinked polyanhydrides
A. Domb (1991)
10.1016/S0169-409X(97)00036-7
Polymeric implants for cancer chemotherapy.
Saltzman (1997)
10.1073/PNAS.90.2.552
Erosion kinetics of hydrolytically degradable polymers.
J. Tamada (1993)
Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.
K. Walter (1994)
10.1016/0142-9612(90)90030-T
Polymers to treat brain tumours.
H. Brem (1990)
10.1023/A:1018995913972
Sustained Local Anesthetic Release from Bioerodible Polymer Matrices: A Potential Method for Prolonged Regional Anesthesia
D. B. Masters (2004)
10.1002/JBM.A.20101
Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity.
A. Shikanov (2004)
10.1016/S0168-3659(96)01510-6
Release of taxol from poly(ϵ-caprolactone) pastes: effect of water-soluble additives
S. Dordunoo (1997)
10.1016/S0378-5173(01)00885-7
Effect of γ-radiation on a polyanhydride implant containing gentamicin sulfate
J. Deng (2002)
10.1016/S0735-1097(88)80046-9
Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients.
M. Nobuyoshi (1988)
10.1016/S0142-9612(98)00108-2
Degradation of double-walled polymer microspheres of PLLA and P(CPP:SA)20:80. I. In vitro degradation.
K. Leach (1998)
10.1016/S0168-3659(99)00205-9
Investigation of the in vitro release of gentamicin from a polyanhydride matrix.
D. Stephens (2000)
10.1097/00005537-200006000-00004
Candidate's Thesis: Polymer Chemotherapy for Head and Neck Cancer
A. Shikani (2000)
10.1021/MA00215A003
Morphological characterization of bioerodible polymers. 1. Crystallinity of polyanhydride copolymers
E. Mathiowitz (1990)
10.1016/S0169-409X(02)00051-0
Polyanhydride degradation and erosion.
A. Göpferich (2002)
10.1016/S0003-2670(02)00468-3
Analysis of fatty acid anhydrides and polyanhydrides
N. Kumar (2002)
10.1016/S0360-3016(98)00296-X
Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.
D. Mohan (1998)
10.1016/S0378-5173(99)00336-1
Pulsatile protein release from a laminated device comprising polyanhydrides and pH-sensitive complexes.
H. Jiang (2000)
10.1002/POLA.1995.080330413
Biodegradable polymers derived from natural fatty acids
A. Domb (1995)
10.1089/SCT.1989.5.55
Biocompatibility of a biodegradable, controlled-release polymer in the rabbit brain.
H. Brem (1989)
10.1016/S0378-5173(99)00087-3
Localized paclitaxel delivery.
A. B. Dhanikula (1999)
Drug delivery and targeting.
R. Langer (1998)
10.1002/POLA.1993.080310523
Absorbable biopolymers derived from dimer fatty acids
A. Domb (1993)
10.1126/SCIENCE.2218494
New methods of drug delivery.
R. Langer (1990)
10.1023/A:1018988222324
Polyanhydride Mierospheres that Display Near-Constant Release of Water-Soluble Model Drug Compounds
Y. Tabata (2004)
10.1002/(SICI)1097-4636(19990605)45:3<258::AID-JBM14>3.0.CO;2-W
Ricinoleic acid-based biopolymers.
D. Teomim (1999)
Optimization of local methylprednisolone delivery to inhibit inflammatory reaction and neointimal hyperplasia of coated coronary stents.
Y. Huang (2002)
10.1016/0168-3659(96)01371-5
Effects of GLIADEL® wafer initial molecular weight on the erosion of wafer and release of BCNU
W. Dang (1996)
Radical surgery in the management of low-grade and high-grade gliomas.
R. Rostomily (1996)
10.1146/annurev.me.13.020162.001051
Chemotherapy of neoplastic diseases.
P. Calabresi (1962)
10.1081/DDC-120006422
The Effect of Storage Temperatures on the In Vitro Properties of a Polyanhydride Implant Containing Gentamicin
Y. Tian (2002)
10.1002/1097-0142(19830915)52:6<997::AID-CNCR2820520612>3.0.CO;2-2
Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas . A joint radiation therapy oncology group and eastern cooperative oncology group study
C. Chang (1983)
10.1002/JBM.820281212
Erosion of a new family of biodegradable polyanhydrides.
L. Shieh (1994)
10.1016/0002-9149(93)91043-H
Molecular biology: insight into the causes and prevention of restenosis after arterial intervention.
J. Wilcox (1993)
10.1016/S0021-9150(01)00618-9
Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials.
A. Gershlick (2002)
10.1016/S0169-409X(02)00050-9
Polyanhydrides: an overview.
N. Kumar (2002)
10.1016/S0168-3659(99)00071-1
Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury.
D. Teomim (1999)
10.1001/ARCHOPHT.1990.01070050128046
Glaucoma filtration surgery in monkeys using 5-fluorouridine in polyanhydride disks.
H. Jampel (1990)
10.1002/APP.1988.070350316
Polyanhydride microspheres as drug carriers. II. Microencapsulation by solvent removal
E. Mathiowitz (1988)
10.1002/JBM.820240708
Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a polyanhydride delivery vehicle.
P. Lucas (1990)
10.1021/MA00108A044
In Situ Atomic Force Microscopy Visualization of the Degradation of Melt-Crystallized Poly(sebacic anhydride)
K. Shakesheff (1995)
10.1002/APP.1992.070450115
Polyanhydride microspheres. IV. Morphology and characterization of systems made by spray drying
E. Mathiowitz (1992)
10.1021/BK-1976-0033
Controlled Release Polymeric Formulations
D. Paul (1976)
10.1080/10601329708011056
Comparison between physical blending and copolymerization of poly(trimethylene carbonate) and poly(adipic anhydride) with special regard to compatibility, morphology and degradation
A. Albertsson (1997)
10.1023/A:1005704913330
Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma
J. A. Williams (2004)
10.1016/S0169-409X(96)00478-4
Biodegradable implant strategies for inhibition of restenosis
L. Orloff (1997)
10.1111/j.1365-2796.1993.tb00979.x
Pathophysiological mechanisms for restenosis following coronary angioplasty: possible preventive alternatives
A. Lövqvist (1993)
10.1016/J.JCONREL.2004.03.001
Delivering DNA from photocrosslinked, surface eroding polyanhydrides.
D. Quick (2004)
10.1161/01.CIR.91.2.541
Gene therapy for cardiovascular disease.
E. Nabel (1995)
10.1016/0142-9612(94)90166-X
Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain.
A. Domb (1994)
10.1016/S0167-7799(99)01356-6
Rationalizing the design of polymeric biomaterials.
N. Angelova (1999)
10.1021/BM0200128
Stereocomplexes of enantiomeric lactic acid and sebacic acid ester-anhydride triblock copolymers.
Raia Slivniak (2002)
10.1016/J.PHARMTHERA.2003.01.001
Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems.
C. A. Kavanagh (2004)
10.1021/MA00198A002
Poly(anhydrides). 3. Poly(anhydrides) based on aliphatic-aromatic diacids
A. Domb (1989)



This paper is referenced by
10.1007/978-1-4614-9434-8_21
Antibiotics Delivery for Treating Bone Infections
Wahid Khan (2014)
10.2217/nnm.13.93
Radiofrequency-triggered release for on-demand delivery of therapeutics from titania nanotube drug-eluting implants.
Manpreet Bariana (2014)
10.1517/17425247.2011.588698
Drug delivery in soft tissue engineering
K. Ladewig (2011)
10.14232/phd.738
Formulation and Investigation of Eroding Hydrophilic Matrix Systems
Baki Gabriella (2011)
10.1517/17425240903307431
Role of in vitro release models in formulation development and quality control of parenteral depots
C. Larsen (2009)
10.1259/bjr.20180745
Novel bioerodable eluting-spacers for radiotherapy applications with in situ dose painting.
F. Boateng (2019)
10.1002/marc.200900029
Design and Synthesis of Fast-Degrading Poly(anhydride-esters).
A. Carbone (2009)
10.1002/jbm.a.35724
Quantitative and qualitative toxicological evaluation of thiol-ene "click" chemistry-based polyanhydrides and their degradation products.
Halimatu S. Mohammed (2016)
10.1002/jps.21346
Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders.
C. Larsen (2008)
10.1002/jbm.a.35086
Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles.
Kathleen A. Ross (2014)
10.1002/9781119041450.CH5
BIOMASS-DERIVED AND BIOMASS-INSPIRED POLYMERS IN PHARMACEUTICAL APPLICATIONS
Elisavet D. Bartzoka (2015)
10.1016/j.jsps.2016.04.022
Preparation and evaluation of rotigotine-loaded implant for the treatment of Parkinson’s disease and its evolution study
Ai-ping Wang (2016)
RECENT ADVANCES IN BRAIN TARGETED DRUG DELIVERY SYSTEMS: A REVIEW
A. gupte (2014)
10.1016/B978-0-12-398523-1.00007-0
Synthetic Biomaterials for Regenerative Medicine Applications
S. Samavedi (2014)
10.1002/9781118015810.CH16
Biodegradable Polymers for Emerging Clinical Use in Tissue Engineering
Shalini Verma (2011)
10.1016/B978-0-08-100963-5.00003-3
3 – Porous scaffolds
Ebru Altuntaş (2017)
10.1016/J.REACTFUNCTPOLYM.2012.06.013
Epoxidation of pendant allyl groups in poly(ester-anhydride)s proposed for application in drug delivery
Katarzyna Jaszcz (2012)
10.1002/PI.4318
Synthesis and properties of a novel hyperbranched polyphosphoramidate using an A2 + CB2 approach
Youhong Liu (2013)
10.2147/IJN.S45317
Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery
Latrisha K. Petersen (2013)
10.1002/jcp.27965
Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets
Negar Ghanaatian (2019)
10.1039/C0JM01668C
A “tool box” for rational design of degradable controlled release formulations
Sam N. Rothstein (2011)
Microsphères résorbables pour embolisation et chimio embolisation
V. Nguyen (2012)
10.1002/9781118015810.CH10
Polyanhydrides‐Poly(CPP‐SA), Fatty‐Acid‐Based Polyanhydrides
Ravikumar M. Borade (2011)
10.1016/j.actbio.2017.01.005
The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
E. I. Wafa (2017)
10.1517/17425247.2.6.1039
Current advances in sustained-release systems for parenteral drug delivery
Y. Shi (2005)
10.1002/adhm.201200214
Silicon micro- and nanofabrication for medicine.
D. Fine (2013)
10.1021/bm500927r
Salicylic acid (SA) bioaccessibility from SA-based poly(anhydride-ester).
Michael A Rogers (2014)
Lauric Acid Derived Polyanhydrides: Synthesis, Characterization, In vitro Degradation and Drug Release Behavior
K. B. Dagbay (2015)
10.1021/bm400889a
Biodegradable polyesters containing ibuprofen and naproxen as pendant groups.
Roselin Rosario-Meléndez (2013)
10.1517/17425247.2012.709844
Recent advances in polymeric microspheres for parenteral drug delivery – part 1
Shi-rui Mao (2012)
10.1533/9781845695033.5.357
Drug release from bioresorbable materials
D. Jones (2008)
10.1208/s12249-008-9126-9
Formulation and Evaluation of PLA and PLGA In Situ Implants Containing Secnidazole and/or Doxycycline for Treatment of Periodontitis
H. Gad (2008)
See more
Semantic Scholar Logo Some data provided by SemanticScholar